Kessler, J. A., Shaibani, A., Sang, C. N., Christiansen, M., Kudrow, D., Vinik, A., & Shin, N. (2021). Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clinical and translational science, 14(3), 1176-1184. https://doi.org/10.1111/cts.12977
Chicago Style (17th ed.) CitationKessler, John A., Aziz Shaibani, Christine N. Sang, Mark Christiansen, David Kudrow, Aaron Vinik, and Nari Shin. "Gene Therapy for Diabetic Peripheral Neuropathy: A Randomized, Placebo‐controlled Phase III Study of VM202, a Plasmid DNA Encoding Human Hepatocyte Growth Factor." Clinical and Translational Science 14, no. 3 (2021): 1176-1184. https://doi.org/10.1111/cts.12977.
MLA (9th ed.) CitationKessler, John A., et al. "Gene Therapy for Diabetic Peripheral Neuropathy: A Randomized, Placebo‐controlled Phase III Study of VM202, a Plasmid DNA Encoding Human Hepatocyte Growth Factor." Clinical and Translational Science, vol. 14, no. 3, 2021, pp. 1176-1184, https://doi.org/10.1111/cts.12977.